紫杉醇诱导体外培养胃腺癌细胞系SGC-7901凋亡

目的：研究紫杉醇对胃腺癌细胞系SGC—7901的凋亡诱导作用。方法：紫杉醇不同浓度、不同作用时间分别处理胃腺癌细胞系SGC—7901。采用MTT法测定胃癌细胞的生长抑制率，通过组织学观察、TUNEL等手段检测胃腺癌细胞系SGC--7901细胞凋亡情况。结果：紫杉醇对胃腺癌细胞系SGC—7901有明显的抑制作用，并在一定剂量和时间范围内诱导胃腺癌细胞系SGC—7901凋亡，随着药物浓度的增加及时间的延长，凋亡细胞明显增多，当紫杉醇作用浓度为20μmol/L以上时，细胞出现破碎、坏死。结论：紫杉醇对胃腺癌细胞系SGC—7901有明显的抑制作用，诱导凋亡是其发挥抗癌作用的机制之一。     

准分子激光原位角膜磨镶术治疗近视后双眼影像不等的临床分析

目的：探讨准分子激光原位角膜磨镶术(LASIK)对近视眼患者双眼影像不等(BA)的影响。方法：采用中国人民解放军海军总医院眼科刘蔼年设计的《双眼影像不等检查图》，对64例行MSIK术的近视眼患者按双眼屈光度差的程度分为四组，术前、术后6个月分别行BA检查，并观察双眼视力与BA恢复的关系。结果：双眼屈光度差≤2.50D的患者术前、术后双眼影像不等的一、二、三类检查图的差异无显著性。屈光度差大于2.50D的患者，术前、术后双眼一、三类检查图的差异有显著性，术后双眼裸眼视力与第三类检查图的恢复密切相关。结论：LASIK术可以使双眼屈光度差值大的患者的BA减小到可以承受的范围，并有助于三级功能的恢复，同时术后视力越好，三级功能恢复越佳。眼科学报2003；19：107-109     

Somatic mosaicism for a MECP2 mutation associated with classic Rett syndrome in a boy

Rett syndrome is a severe neurodevelopmental disorder that arises from mutations in the X-linked MECP2 gene. It is almost exclusively seen in girls due to the predominant occurrence of the mutations on the paternal X-chromosome, and also the early postnatal lethal effect of the disease causing mutations in hemizygous boys. We identified a boy with features of classic Rett syndrome who is mosaic for the truncating MECP2 mutation R270X. Chromosome analysis showed normal karyotype. These results indicate that a MECP2 mutation associated with Rett syndrome in females could lead to a similar phenotype in males as a result of somatic mosaicism.     

Calcium channel blockers prevent stress-induced ulcers in rats

Gastric mucosal damaged induced by cold and restraint stress caused increase in gastric lipid peroxidation (LP) and decrease in gastric glutathione levels. Two calcium-channel blockers, verapamil and nicardipine, prevented stress-induced increase in gastric LP, as well as ulcer formation. Both calcium-channel blockers protected against stress-induced ulcers, and inhibition of LP may be among their mechanisms of action.In memory of Dr. Ilker Aykaç whom we have started with.     

Systemic mastocytosis. Report of a case

The case of a 20-year-old woman with systemic mastocytosis is reported. The disorder was not preceded by a clinically diagnosed local form of the disease; fibrous changes in organs, bone changes, eosinophilia and increased serotonin, heparin or histamine levels had not been observed. Clinical symptomatology was typical and the patient died one year after the first signs of the disease.     

Intra-Arterial Infusion Chemotherapy in the Treatment of Locally Advanced Breast Cancer

The efficacy of intra-arterial infusion chemotherapy (IACT) as the first step in a combined modality therapy in the treatment of locally advanced breast cancer was evaluated in a prospective clinical study consisting of 18 patients, 15 with stage IIIB, and three with stage IV breast cancer. A combined chemotherapy using adriamycin, mitomycin C and 5-Fluorouracil were administered at 3-week intervals until sufficient regression was achieved. Objective response rate was 66.6%. Among the 14 patients who received IACT for induction, plus surgery, simultaneous adjuvant chemotherapy and radiotherapy, 7 were disease-free at a mean of 19.5 (range 4-42) months. Six patients developed various relapses at a mean of 20.6 (range 12-28) months. IACT was found to be quite effective in local control. The early systemic relapse continues to be a serious problem that needs further intervention.     

The relationship between mean platelet volume with microalbuminuria and glycemic control in patients with type II diabetes mellitus

Microalbuminuria is the best predictor of diabetic nephropathy development in patients with type II diabetes mellitus (DM). It is also accepted as an indicator of diabetic microangiopathy. Increased activation of platelets has been suggested to be involved in the pathogenesis of vascular complications. In light of these findings, this study was designed to investigate the association of microalbuminuria - an indicator glycemic control and microangiopathy - with mean platelet volume (MPV). Subjects underwent laboratory analyses and their MPV, HbA1c, serum creatinine, fasting, and postprandial blood glucose levels and 24-hour urine albumin levels were recorded. All statistical analyses were performed using SPSS v13.0 for Windows XP. Mann-Whitney U-test, student's t-test, spearman correlation analysis, ROC analysis, categorical regression analysis, and chi-square test were used for statistical evaluations. The study included 354 patients with type II DM. The median MPV value of microalbuminuria-positive patients was 9 (8-9.5) fl while MPV of patients without microalbuminuria was 8.5 (8-9.2) fl and the difference was statistically significant (p=0.004). We determined positive correlation between MPV and 24-hour urine microalbuminuria (r=0.14, p=0.009). There were no significant differences between patients with HbA1c levels below and above 7% in terms of MPV (p>0.05). We determined no correlation between MPV and HbA1c levels (r=?-0.36, p=0.64). This study determined a significant positive relationship between microalbuminuria - a microvascular complication of diabetes - and MPV. No significant correlation was identified between poor glycemic control and MPV in diabetic patients. However, we are in the opinion that the association between poor glycemic control and MPV in type II diabetic patients should be investigated in prospective studies with larger samples.     

Lamotrigine augmentation in patients with schizophrenia who show partial response to clozapine treatment

BackgroundSeveral placebo controlled studies investigating lamotrigine augmentation of clozapine in schizophrenia patients with partial response have shown varying results. The aim of this study was to further investigate the efficacy and safety of this augmentation strategy, and its effect on the glutamatergic system through utilizing mismatch negativity (MMN) component of auditory event related potentials.MethodsThe study was designed to evaluate the efficacy and safety of lamotrigine augmentation of clozapine in a 12-week, double-blind, placebo-controlled, prospective, randomized design. Thirty-four patients diagnosed according to DSM-IV schizophrenia criteria and with partial response to clozapine were included. Patients were randomized to 25 mg/day of lamotrigine or placebo, gradually increasing up to 200 mg/day on the 6th week. The change in psychopathology was assessed with Positive and Negative Syndrome (PANSS), Calgary Depression (CDS) and Clinical Global Impression-Severity (CGI-S) scales. A neuropsychological test battery was administered and MMN measurements were also obtained at baseline and endpoint. Safety evaluation included physical examination, UKU Side Effect Rating Scale (UKU) assessment and serum drug level measurements.ResultsNo significant differences were found between the two treatment groups in PANSS Positive and General Psychopathology, CDS, neurocognitive test and UKU scores, as well as MMN measurements. PANSS Total, Negative and CGI-S scores showed significant improvement compared to lamotrigine in the placebo group.ConclusionThis study did not show any benefit of augmentation of clozapine with lamotrigine in schizophrenia patients with partial response. The need for further investigation of other augmentation strategies of clozapine in partially responsive schizophrenia patients is evident.     

A new surgical technique for adenoid cystic carcinoma involving tracheal carina

Reported is the successful treatment of a 24-year-old male with adenocystic carcinoma involving the tracheal carina, in which the tumor extended along the right main bronchus across the orifice of the right upper lobe. The patient underwent a carinal resection plus right upper lobectomy and reconstruction of the carina, resulting in neither anastomotic complication nor recurrence of disease during 28 months of follow-up.